IL98394A - WS7622a mono or di-sulfate, salts thereof, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

WS7622a mono or di-sulfate, salts thereof, processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL98394A
IL98394A IL9839491A IL9839491A IL98394A IL 98394 A IL98394 A IL 98394A IL 9839491 A IL9839491 A IL 9839491A IL 9839491 A IL9839491 A IL 9839491A IL 98394 A IL98394 A IL 98394A
Authority
IL
Israel
Prior art keywords
ws7622a
sulfate
salt
pharmaceutically acceptable
amino acid
Prior art date
Application number
IL9839491A
Other languages
English (en)
Other versions
IL98394A0 (en
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL98394A0 publication Critical patent/IL98394A0/xx
Publication of IL98394A publication Critical patent/IL98394A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
IL9839491A 1990-06-29 1991-06-06 WS7622a mono or di-sulfate, salts thereof, processes for the preparation thereof and pharmaceutical compositions containing the same IL98394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (2)

Publication Number Publication Date
IL98394A0 IL98394A0 (en) 1992-07-15
IL98394A true IL98394A (en) 1995-03-30

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9839491A IL98394A (en) 1990-06-29 1991-06-06 WS7622a mono or di-sulfate, salts thereof, processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (22)

Country Link
US (2) US5292510A (de)
EP (1) EP0465895B1 (de)
JP (1) JP2663763B2 (de)
KR (1) KR100198693B1 (de)
CN (1) CN1073115C (de)
AT (1) ATE138074T1 (de)
AU (1) AU640241B2 (de)
CA (1) CA2045761C (de)
DE (1) DE69119488T2 (de)
DK (1) DK0465895T3 (de)
ES (1) ES2087178T3 (de)
FI (1) FI106554B (de)
GB (1) GB9014546D0 (de)
GR (1) GR3020184T3 (de)
HU (1) HU213398B (de)
IE (1) IE75702B1 (de)
IL (1) IL98394A (de)
NO (1) NO301643B1 (de)
PH (1) PH31239A (de)
PT (1) PT98134B (de)
RU (1) RU2087482C1 (de)
ZA (1) ZA914349B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111013T3 (es) * 1991-06-18 1998-03-01 Fujisawa Pharmaceutical Co Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
IE912047A1 (en) 1992-01-01
KR920000920A (ko) 1992-01-29
AU7939491A (en) 1992-01-09
HU912198D0 (en) 1991-12-30
RU2087482C1 (ru) 1997-08-20
GR3020184T3 (en) 1996-09-30
PT98134B (pt) 1998-12-31
NO912561L (no) 1991-12-30
CN1057655A (zh) 1992-01-08
FI912914L (fi) 1991-12-30
PT98134A (pt) 1992-06-30
US5364624A (en) 1994-11-15
EP0465895A1 (de) 1992-01-15
NO301643B1 (no) 1997-11-24
IL98394A0 (en) 1992-07-15
DE69119488D1 (de) 1996-06-20
ATE138074T1 (de) 1996-06-15
ZA914349B (en) 1992-03-25
JP2663763B2 (ja) 1997-10-15
US5292510A (en) 1994-03-08
CA2045761A1 (en) 1991-12-30
HU213398B (en) 1997-06-30
IE75702B1 (en) 1997-09-10
AU640241B2 (en) 1993-08-19
FI106554B (fi) 2001-02-28
EP0465895B1 (de) 1996-05-15
FI912914A0 (fi) 1991-06-17
HUT58351A (en) 1992-02-28
GB9014546D0 (en) 1990-08-22
DE69119488T2 (de) 1996-10-02
CN1073115C (zh) 2001-10-17
JPH04279600A (ja) 1992-10-05
NO912561D0 (no) 1991-06-28
KR100198693B1 (ko) 1999-06-15
DK0465895T3 (da) 1996-06-03
PH31239A (en) 1998-06-18
CA2045761C (en) 1999-09-21
ES2087178T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
JP4316672B2 (ja) ラムノリピド類の免疫活性
IL98394A (en) WS7622a mono or di-sulfate, salts thereof, processes for the preparation thereof and pharmaceutical compositions containing the same
CZ289311B6 (cs) Cyklopeptolidy, způsoby jejich připravy a terapeutický prostředek, který je obsahuje
US7098024B2 (en) Depsipeptide compound
CA2071425C (en) Prophylactic/therapeutic composition for disseminated intravascular coagulation, or chronic respiratory tract infectious disease
BRPI0909142B1 (pt) composto cíclico e sal do mesmo, seu uso, seu processo de preparação, e composição farmacêutica
EP0387712B1 (de) Substanzen WS 7622 A,B,C und D, deren Derivate, Verfahren zu deren Herstellung sowie deren Verwendung
Poulos et al. Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies
JPS595150A (ja) 抗微生物性ジスルフイドプロドラツグ
EP1081151A1 (de) Neue physiologisch aktive substanzen
US7625870B2 (en) Peptide substance restoring respiratory organs function
KR20020050235A (ko) 난치성 창상의 치료제
JP2002161051A (ja) 脳虚血性疾患等の治療剤
TW202391B (de)
JPH05221872A (ja) Ｗｓ７６２２ａモノまたはジ硫酸エステルを含む医薬組成物
JPWO1998027998A1 (ja) 脳虚血性疾患等の治療剤
WO1995018142A1 (en) Wf15604 substances
JPWO2001026685A1 (ja) 難治性創傷の治療剤
HK1014011B (en) Cyclopeptolides
MXPA01003742A (en) Cyclic tetrapeptide compound and use thereof

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)